Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11392211PMC
http://dx.doi.org/10.1097/JS9.0000000000001628DOI Listing

Publication Analysis

Top Keywords

celebrating breakthrough
4
breakthrough fda
4
fda greenlights
4
greenlights triclip
4
triclip tricuspid
4
tricuspid regurgitation
4
regurgitation editorial
4
celebrating
1
fda
1
greenlights
1

Similar Publications

Mitigating Antibiotic Resistance: The Utilization of CRISPR Technology in Detection.

Biosensors (Basel)

December 2024

Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security, State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou 310018, China.

Antibiotics, celebrated as some of the most significant pharmaceutical breakthroughs in medical history, are capable of eliminating or inhibiting bacterial growth, offering a primary defense against a wide array of bacterial infections. However, the rise in antimicrobial resistance (AMR), driven by the widespread use of antibiotics, has evolved into a widespread and ominous threat to global public health. Thus, the creation of efficient methods for detecting resistance genes and antibiotics is imperative for ensuring food safety and safeguarding human health.

View Article and Find Full Text PDF

Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease.

Ann Med Surg (Lond)

August 2024

Department of research, Medical Research Circle, Goma, Democratic Republic of Congo.

Sickle cell disease (SCD) is a hereditary hemoglobinopathy resulting from a β-globin chain mutation that causes abnormal hemoglobin (HbS) polymerization and leads to severe complications. Current treatment options primarily focus on symptom management, with limited curative potential. Recently, Casgevy, the first CRISPR/Cas9-based gene therapy for SCD, has received breakthrough FDA approval.

View Article and Find Full Text PDF

Professor John Roderick Cameron (1922-2005) stands out as a trailblazer in the field of medical physics, whose innovative work has deeply influenced radiation protection and the broader medical radiation field through sound technical judgment and insight. Best known for inventing the bone densitometry device, his pioneering efforts have reshaped modern medical practices far beyond his initial breakthroughs. Cameron's explorations extended into the realms of space biomedical science and models of terrestrial radiation, areas where his insights continue to resonate today.

View Article and Find Full Text PDF

Robert S. Schwartz, MD, a transformative figure in immunosuppression that revolutionized transplantation.

Front Transplant

August 2023

Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Houston, TX, United States.

While the transplant community celebrated more than a million transplant patients in the United States, we are reminded that our journey to such a celebratory success is the results of remarkable breakthroughs and brilliant innovators. Among those, immunosuppression drugs are undoubtedly a cornerstone of transplant success, an area where Dr. Robert Schwartz is undeniably a transformative figure and a pioneer.

View Article and Find Full Text PDF

A decade ago, in 2013, and over the course of 4 summer months, three separate observations were reported that each shed light independently on a new molecular organization that fundamentally reshaped our perception of excitatory synaptic transmission (Fukata et al., 2013; MacGillavry et al., 2013; Nair et al.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!